129 related articles for article (PubMed ID: 2703180)
1. Use of CA 125 to monitor patients with ovarian epithelial carcinomas.
Podczaski E; Whitney C; Manetta A; Larson JE; Kirk J; Stevens CW; Lyter J; Mortel R
Gynecol Oncol; 1989 May; 33(2):193-7. PubMed ID: 2703180
[TBL] [Abstract][Full Text] [Related]
2. Value of serum 125Ca levels: does the result preclude second look?
Potter ME; Moradi M; To AC; Hatch KD; Shingleton HM
Gynecol Oncol; 1989 May; 33(2):201-3. PubMed ID: 2703182
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of CA 125 and histological findings at second-look laparotomy in ovarian carcinoma.
Meier W; Stieber P; Eiermann W; Schneider A; Fateh-Moghadam A; Hepp H
Gynecol Oncol; 1989 Oct; 35(1):44-6. PubMed ID: 2792900
[TBL] [Abstract][Full Text] [Related]
4. CA 125 measured before second-look laparotomy is an independent prognostic factor for survival in patients with epithelial ovarian cancer.
Makar AP; Kristensen GB; Børmer OP; Tropé CG
Gynecol Oncol; 1992 Jun; 45(3):323-8. PubMed ID: 1612511
[TBL] [Abstract][Full Text] [Related]
5. Does serum CA-125 level prior to second-look laparotomy for invasive ovarian adenocarcinoma predict size of residual disease?
Patsner B; Orr JW; Mann WJ; Taylor PT; Partridge E; Allmen T
Gynecol Oncol; 1990 Jun; 37(3):319-22. PubMed ID: 2190870
[TBL] [Abstract][Full Text] [Related]
6. Survival of patients with ovarian epithelial carcinomas after second-look laparotomy.
Podczaski E; Manetta A; Kaminski P; Ricelli A; Larson J; DeGeest K; Mortel R
Gynecol Oncol; 1990 Jan; 36(1):43-7. PubMed ID: 2295451
[TBL] [Abstract][Full Text] [Related]
7. Use of second-look laparotomy in the management of patients with ovarian epithelial malignancies.
Podczaski ES; Stevens CW; Manetta A; Whitney CW; Larson JE; Mortel R
Gynecol Oncol; 1987 Oct; 28(2):205-14. PubMed ID: 3666578
[TBL] [Abstract][Full Text] [Related]
8. Does serum CA-125 level prior to second-look laparotomy for invasive ovarian adenocarcinoma predict size of residual disease?
Patsner B; Orr JW; Mann WJ; Taylor PT; Partridge E; Allmen T
Gynecol Oncol; 1990 Sep; 38(3):373-6. PubMed ID: 2227551
[TBL] [Abstract][Full Text] [Related]
9. Measurement of the ovarian cancer-associated antigen CA 125 prior to second look operation.
Mogensen O; Mogensen B; Jakobsen A; Sell A
Eur J Cancer Clin Oncol; 1988 Dec; 24(12):1835-7. PubMed ID: 3220081
[TBL] [Abstract][Full Text] [Related]
10. The prognostic implications of low serum CA 125 levels prior to the second-look operation for stage III and IV epithelial ovarian cancer.
Gallion HH; Hunter JE; van Nagell JR; Averette HE; Cain JM; Copeland LJ; Higgins RV; Husseinzadeh N; Nahhas WA; Partridge EE
Gynecol Oncol; 1992 Jul; 46(1):29-32. PubMed ID: 1634137
[TBL] [Abstract][Full Text] [Related]
11. Second-look laparotomy in epithelial ovarian carcinoma. Prognostic factors associated with survival duration.
Lippman SM; Alberts DS; Slymen DJ; Weiner S; Aristizabal SA; Luditch A; Davis JR; Surwit EA
Cancer; 1988 Jun; 61(12):2571-7. PubMed ID: 3365677
[TBL] [Abstract][Full Text] [Related]
12. Serum CA 125 levels and surgical findings in patients undergoing secondary operations for epithelial ovarian cancer.
Rubin SC; Hoskins WJ; Hakes TB; Markman M; Reichman BS; Chapman D; Lewis JL
Am J Obstet Gynecol; 1989 Mar; 160(3):667-71. PubMed ID: 2648838
[TBL] [Abstract][Full Text] [Related]
13. [Serum CA 125 values and histologic findings at the time of second-look laparotomy in ovarian cancer].
Meier W; Stieber P; Fateh-Moghadam A; Eiermann W; Hepp H
Geburtshilfe Frauenheilkd; 1988 May; 48(5):331-3. PubMed ID: 3165078
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of second-look laparotomy for ovarian cancer: second-look vs. serum CA125.
Liu L; Hong W; Hou Y; Yao Z; Wu A; Wang X
Chin Med Sci J; 1991 Jun; 6(2):96-9. PubMed ID: 1804384
[TBL] [Abstract][Full Text] [Related]
15. [Relationship between serum CA125 level and second-look findings in ovarian cancers].
Liu LY
Zhonghua Zhong Liu Za Zhi; 1992 Jul; 14(4):287-9. PubMed ID: 1327702
[TBL] [Abstract][Full Text] [Related]
16. Tumor markers of epithelial and stromal cell origin at second-look laparotomy in ovarian carcinoma.
Tomás C; Kauppila A
Gynecol Oncol; 1992 Jun; 45(3):279-83. PubMed ID: 1612504
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of the CA 125 assay in monitoring of ovarian cancer patients.
Hising C; Anjegård IM; Einhorn N
Am J Clin Oncol; 1991 Apr; 14(2):111-4. PubMed ID: 2028919
[TBL] [Abstract][Full Text] [Related]
18. Is CA-125 monitoring useful in patients with epithelial ovarian carcinoma and preoperative negative CA-125 serum levels?
Sevelda P; Rosen A; Denison U; Barrada M; Spona J; Salzer H
Gynecol Oncol; 1991 Nov; 43(2):154-8. PubMed ID: 1743558
[TBL] [Abstract][Full Text] [Related]
19. CA 125 serum levels correlated with second-look operations among ovarian cancer patients.
Berek JS; Knapp RC; Malkasian GD; Lavin PT; Whitney C; Niloff JM; Bast RC
Obstet Gynecol; 1986 May; 67(5):685-9. PubMed ID: 3457330
[TBL] [Abstract][Full Text] [Related]
20. [Second-look laparotomy in epithelial ovarian cancer: an evaluation of 23 cases].
Liu LY
Zhonghua Fu Chan Ke Za Zhi; 1990 Mar; 25(2):77-9, 123. PubMed ID: 2364794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
